Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey

被引:11
作者
Magnani, Clement [1 ]
Ben Smith, Allan [2 ,3 ]
Rey, Dominique [4 ]
Sarradon-Eck, Aline [4 ,5 ]
Preau, Marie [6 ,7 ]
Bendiane, Marc-Karim [4 ]
Bouhnik, Anne-Deborah [4 ]
Mancini, Julien [8 ]
机构
[1] Aix Marseille Univ, Marseille, France
[2] Ingham Inst Appl Med Res, Sydney, NSW, Australia
[3] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia
[4] Aix Marseille Univ, Equipe CANBIOS Labellisee Ligue 2019, INSERM,IRD,ISSPAM, SESSTIM,Sci Econ & Sociales Sante & Traitement In, Marseille, France
[5] Inst Paoli Calmettes, SESSTIM, Marseille, France
[6] Unite UMR 1296 Radiat Def Sante Environm, Lyon, France
[7] Univ Lumiere Lyon 2, Inst Psychol, Bron, France
[8] Aix Marseille Univ, Hop Timone,BioSTIC,Biostat & Technol Informat & C, AP HM,ISSPAM,Equipe CANBIOS Labellisee Ligue 2019, INSERM,IRD,SESSTIM,Sci Econ & Sociales Sante & Tr, Marseille, France
关键词
Cancer survivors; Fear of recurrence; General practitioner; Breast; Thyroid; Melanoma; QUALITY-OF-LIFE; FOLLOW-UP CARE; BREAST-CANCER; HEALTH LITERACY; SURVIVORS; ASSOCIATION; PROGRESSION; PREVALENCE; VALIDATION; DEPRESSION;
D O I
10.1007/s11764-022-01193-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Fear of cancer recurrence (FCR) is frequent in survivors, but less is known about FCR in long-term survivors with very low risk of relapse. Our aim was to estimate the prevalence and clinical and socio-behavioural factors associated with FCR in young women 5 years after diagnosis of a good-prognosis cancer. Methods Using data from the VICAN-5 survey, conducted in 2015-2016 amongst a national representative French sample of cancer survivors, we included women with non-metastatic melanoma, breast, or thyroid cancer, aged 55 years or under at diagnosis, who experienced no disease progression in the 5 years post-diagnosis. Multinomial logistic regression was used to identify factors associated with FCR, characterised using a three-level indicator: no, mild, and moderate/severe FCR. Results Amongst the 1153 women included, mean age was 44 years at diagnosis, and 81.8% had breast cancer, 12.5% thyroid cancer, and 5.8% melanoma. Five years after diagnosis, 35.4% reported no FCR, 46.0% mild FCR, and 18.6% moderate/severe FCR. Women with thyroid cancer were less likely to suffer from mild or moderate/severe FCR, while cancer-related treatment sequelae, fatigue, and anxiety were more likely. Limited health literacy was associated with mild FCR. Women who reported only occasionally consulting a general practitioner (GP) for the management of their cancer had a higher probability of FCR. Conclusion Moderate/severe FCR affected nearly 20% of young female long-term survivors diagnosed with a good-prognosis cancer, particularly those reporting cancer-related sequelae, suffering from fatigue or anxiety, with breast cancer or melanoma (versus thyroid cancer), and consulting a GP only occasionally for cancer management. I mplications for Cancer Survivors Given the recognised impact of FCR on quality of life, it is essential to detect it as early as possible, and to implement targeted interventions in routine care.
引用
收藏
页码:1359 / 1370
页数:12
相关论文
共 66 条
[1]   Follow-up care for cancer survivors: views of the younger adult [J].
Absolom, K. ;
Eiser, C. ;
Michel, G. ;
Walters, S. J. ;
Hancock, B. W. ;
Coleman, R. E. ;
Snowden, J. A. ;
Greenfield, D. M. .
BRITISH JOURNAL OF CANCER, 2009, 101 (04) :561-567
[2]   Spotlight on the Fear of Cancer Recurrence Inventory (FCRI) [J].
Ben Smith, Allan ;
Costa, Daniel ;
Galica, Jacqueline ;
Lebel, Sophie ;
Tauber, Nina ;
van Helmondt, Sanne Jasperine ;
Zachariae, Robert .
PSYCHOLOGY RESEARCH AND BEHAVIOR MANAGEMENT, 2020, 13 :1257-1268
[3]   Integrating fear of cancer recurrence screening into routine care: opportunities and challenges [J].
Ben Smith, Allan .
PSYCHO-ONCOLOGY, 2021, 30 (01) :134-137
[4]   Effect of endocrine treatment on sexuality in premenopausal breast cancer patients:: A prospective randomized study [J].
Berglund, G ;
Nystedt, M ;
Bolund, C ;
Sjödén, PO ;
Rutquist, LE .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (11) :2788-2796
[5]   Cancer mortality in Europe in 2015 and an overview of trends since 1990 [J].
Bertuccio, P. ;
Alicandro, G. ;
Malvezzi, M. ;
Carioli, G. ;
Boffetta, P. ;
Levi, F. ;
La Vecchia, C. ;
Negri, E. .
ANNALS OF ONCOLOGY, 2019, 30 (08) :1356-1369
[6]   Depression, Anxiety and Quality of Life in Long-Term Survivors of Malignant Melanoma: A Register-Based Cohort Study [J].
Beutel, Manfred E. ;
Fischbeck, Sabine ;
Binder, Harald ;
Blettner, Maria ;
Braehler, Elmar ;
Emrich, Katharina ;
Friedrich-Mai, Peter ;
Imruck, Barbara H. ;
Weyer, Veronika ;
Zeissig, Sylke R. .
PLOS ONE, 2015, 10 (01)
[7]   The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey) [J].
Bouhnik, Anne-Deborah ;
Bendiane, Marc-Karim ;
Cortaredona, Sebastien ;
Teyssier, Luis Sagaon ;
Rey, Dominique ;
Berenger, Cyril ;
Seror, Valerie ;
Peretti-Watel, Patrick .
BMJ OPEN, 2015, 5 (03)
[8]  
Burdine JN, 2000, HEALTH SERV RES, V35, P885
[9]   Health literacy impacts self-management, quality of life and fear of recurrence in head and neck cancer survivors [J].
Clarke, Nicholas ;
Dunne, Simon ;
Coffey, Laura ;
Sharp, Linda ;
Desmond, Deirdre ;
O'Conner, Jean ;
O'Sullivan, Eleanor ;
Timon, Conrad ;
Cullen, Claire ;
Gallagher, Pamela .
JOURNAL OF CANCER SURVIVORSHIP, 2021, 15 (06) :855-865
[10]   The sum of all fears: conceptual challenges with measuring fear of cancer recurrence [J].
Costa, Daniel S. J. ;
Smith, Allan Ben ;
Fardell, Joanna E. .
SUPPORTIVE CARE IN CANCER, 2016, 24 (01) :1-3